Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Rocket Pharmaceuticals Inc’s stock clocked out at $12.35, down -1.67% from its previous closing price of $12.56. In other words, the price has decreased by -$1.67 from its previous closing price. On the day, 1.16 million shares were traded. RCKT stock price reached its highest trading level at $12.94 during the session, while it also had its lowest trading level at $12.32.
Ratios:
To gain a deeper understanding of RCKT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.05 and its Current Ratio is at 6.05. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on December 30, 2024, initiated with a Outperform rating and assigned the stock a target price of $32.
On December 18, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $29.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 21 ’24 when Militello John sold 1,224 shares for $13.05 per share. The transaction valued at 15,978 led to the insider holds 49,310 shares of the business.
Patel Kinnari sold 4,588 shares of RCKT for $59,892 on Nov 21 ’24. The insider now owns 392,395 shares after completing the transaction at $13.05 per share. On Nov 21 ’24, another insider, Shah Gaurav, who serves as the CEO of the company, sold 11,091 shares for $13.05 each. As a result, the insider received 144,782 and left with 707,328 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 1313261952 and an Enterprise Value of 915769984.
Stock Price History:
The Beta on a monthly basis for RCKT is 1.00, which has changed by -0.5732246 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $31.47, while it has fallen to a 52-week low of $11.15. The 50-Day Moving Average of the stock is -12.83%, while the 200-Day Moving Average is calculated to be -37.01%.
Shares Statistics:
It appears that RCKT traded 1.11M shares on average per day over the past three months and 1738180 shares per day over the past ten days. A total of 106.34M shares are outstanding, with a floating share count of 96.86M. Insiders hold about 8.91% of the company’s shares, while institutions hold 84.92% stake in the company. Shares short for RCKT as of 1734048000 were 11175314 with a Short Ratio of 10.08, compared to 1731628800 on 11092305. Therefore, it implies a Short% of Shares Outstanding of 11175314 and a Short% of Float of 19.2.
